North East and North Cumbria
ICS Formulary
1 Gastro-intestinal system
01-07-04 Management of anal fissures
Glyceryl Trinitrate 0.4% ointment
Rectogesic
®
First Choice
0.2% also available
unlicensed.
Botulinum toxin type A
Formulary
Approved for use by specialists as an alternative to surgery in patients failing other treatments. Also approved for use in paediatrics but there must be documented informed consent from patients/carers.
MHRA DSU (July 2026): Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism
Diltiazem 2%
Formulary
The most effective formulation is to be prescribed
Links
Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities
MHRA DSU (July 2026): Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulism
NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence
Key
Full Site